Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Cytek Biosciences (CTKB) Inventory Average (2021 - 2025)

Historic Inventory Average for Cytek Biosciences (CTKB) over the last 5 years, with Q3 2025 value amounting to $50.6 million.

  • Cytek Biosciences' Inventory Average rose 440.38% to $50.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $50.6 million, marking a year-over-year increase of 440.38%. This contributed to the annual value of $52.4 million for FY2024, which is 390.81% down from last year.
  • As of Q3 2025, Cytek Biosciences' Inventory Average stood at $50.6 million, which was up 440.38% from $47.4 million recorded in Q2 2025.
  • Cytek Biosciences' Inventory Average's 5-year high stood at $67.6 million during Q2 2023, with a 5-year trough of $27.1 million in Q3 2021.
  • In the last 5 years, Cytek Biosciences' Inventory Average had a median value of $48.4 million in 2024 and averaged $49.0 million.
  • In the last 5 years, Cytek Biosciences' Inventory Average skyrocketed by 7485.88% in 2022 and then tumbled by 2900.85% in 2024.
  • Quarter analysis of 5 years shows Cytek Biosciences' Inventory Average stood at $29.8 million in 2021, then soared by 63.4% to $48.8 million in 2022, then surged by 31.0% to $63.9 million in 2023, then decreased by 29.01% to $45.3 million in 2024, then rose by 11.51% to $50.6 million in 2025.
  • Its Inventory Average was $50.6 million in Q3 2025, compared to $47.4 million in Q2 2025 and $44.6 million in Q1 2025.